Cilengitide with cetuximab, cisplatin, and 5-FU in recurrent and/or metastatic squamous cell cancer of the head and neck: the phase II ADVANTAGE trial

Gauler, TC; Clement, Paul; Peyrade, F; Krauss, J; Mesia, R; Remenar, E; Keilholz, U; Delord, JP; Schafhausen, P; Erfan, J; Brummendorf, TH; Iglesias, L; Bethe, U; Hicking, C; Vermorken, JB

Onkologie

Cilengitide with cetuximab, cisplatin, and 5-FU in recurrent and/or metastatic squamous cell cancer of the head and neck: the phase II ADVANTAGE trial

Author:

Gauler, TC

Clement, Paul ; Peyrade, F ; Krauss, J ; Mesia, R ; Remenar, E ; Keilholz, U ; Delord, JP ; Schafhausen, P ; Erfan, J ; Brummendorf, TH ; Iglesias, L ; Bethe, U ; Hicking, C ; Vermorken, JB

Keywords:

Science & Technology, Life Sciences & Biomedicine, Oncology, 1103 Clinical Sciences, Oncology & Carcinogenesis, 3202 Clinical sciences

Onkologie Cilengitide with cetuximab, cisplatin, and 5-FU in recurrent and/or metastatic squamous cell cancer of the head and neck: the phase II ADVANTAGE trial

Author:

Keywords:

Onkologie

Cilengitide with cetuximab, cisplatin, and 5-FU in recurrent and/or metastatic squamous cell cancer of the head and neck: the phase II ADVANTAGE trial